We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-0.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$60.5B
AUM Growth
+$2.39B
(+4.1%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
17.56%
Holding
4,827
New
882
Increased
1,455
Reduced
1,567
Closed
849
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.29B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$673M |
| 3 |
VanEck Semiconductor ETF
SMH
|
+$170M |
| 4 |
Oracle
ORCL
|
+$168M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$210M |
| 2 |
UnitedHealth
UNH
|
+$158M |
| 3 |
Netflix
NFLX
|
+$140M |
| 4 |
Dollar General
DG
|
+$135M |
| 5 |
Micron Technology
MU
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Consumer Discretionary | 6.01% |
| 3 | Healthcare | 4.63% |
| 4 | Industrials | 4.29% |
| 5 | Financials | 4.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Alto Ingredients
ALTO
$360M
| $47.3K | ﹤0.01% |
32,740
-11,230
| -26% | -$19.4K |
|
|
LLAP
3902
DELISTED
Terran Orbital Corporation
LLAP
| $46.6K | ﹤0.01% |
+56,870
| New | +$61K |
|
|
IMA
3903
ImageneBio Inc
IMA
$63.1M
| $45.6K | ﹤0.01% |
+2,306
| New | +$40.7K |
|
3904
Immix Biopharma
IMMX
$607M
| $45.6K | ﹤0.01% |
+23,010
| New | +$52.9K |
|
3905
CarParts.com
PRTS
$42.8M
| $45.3K | ﹤0.01% |
+4,530
| New | +$55.1K |
|
|
GPMT
3906
Granite Point Mortgage Trust
GPMT
$63.7M
| $44.9K | ﹤0.01% |
+15,102
| New | +$55.9K |
|
|
UNIT
3907
Uniti Group
UNIT
$2.63B
| $44.4K | ﹤0.01% |
+15,199
| New | +$63.7K |
|
3908
Lineage Cell Therapeutics
LCTX
$257M
| $44.2K | ﹤0.01% |
44,307
-147,588
| -77% | -$163K |
|
3909
BioXcel Therapeutics
BTAI
$26.2M
| $43.8K | ﹤0.01% |
+2,141
| New | +$71.7K |
|
|
BCOV
3910
DELISTED
Brightcove, Inc.
BCOV
| $43.7K | ﹤0.01% |
18,455
+1,341
| +8% | +$2.63K |
|
3911
InflaRx
IFRX
$256M
| $43.6K | ﹤0.01% |
25,072
+8,207
| +49% | +$12K |
|
|
TIGR
3912
UP Fintech Holding
TIGR
$845M
| $43.5K | ﹤0.01% |
10,362
-20,099
| -66% | -$79.3K |
|
3913
Rallybio
RLYB
$86.6M
| $42.8K | ﹤0.01% |
3,990
-563
| -12% | -$7.63K |
|
3914
Riverview Bancorp
RVSB
$107M
| $42.5K | ﹤0.01% |
+10,645
| New | +$43.6K |
|
|
SPI
3915
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
| $42K | ﹤0.01% |
93,335
+58,443
| +167% | +$31.3K |
|
|
LILM
3916
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $41.7K | ﹤0.01% |
+52,505
| New | +$49.2K |
|
3917
Metagenomi Therapeutics
MGX
$45.6M
| $41.6K | ﹤0.01% |
10,202
-16,286
| -61% | -$112K |
|
3918
Innoviz Technologies
INVZ
$135M
| $40.9K | ﹤0.01% |
+44,120
| New | +$49.5K |
|
3919
Polestar Automotive Holding UK
PSNY
$1.98B
| $40.7K | ﹤0.01% |
+1,723
| New | +$57.6K |
|
3920
ProKidney
PROK
$308M
| $40.3K | ﹤0.01% |
16,377
-21,373
| -57% | -$57.4K |
|
|
GRTS
3921
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $40.1K | ﹤0.01% |
+64,929
| New | +$54.9K |
|
3922
Cardiff Oncology
CRDF
$64.3M
| $40.1K | ﹤0.01% |
18,045
+532
| +3% | +$2K |
|
|
FARM
3923
DELISTED
Farmer Brothers
FARM
| $39.8K | ﹤0.01% |
+14,850
| New | +$45.6K |
|
3924
VistaGen Therapeutics
VTGN
$9.29M
| $39.7K | ﹤0.01% |
+11,395
| New | +$49.3K |
|
|
TSBX
3925
DELISTED
Turnstone Biologics
TSBX
| $39.3K | ﹤0.01% |
+15,018
| New | +$42.9K |
|
Similar funds
Squarepoint's Q2 2024 Portfolio in Review
As of Q2 2024, Squarepoint held 4,827 positions worth $60.5B, up 4.1% from $58.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Squarepoint's Q2 2024 filing shows 882 new, 1,455 increased, 1,567 reduced and 849 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M. The largest sale was Apple, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Squarepoint's largest Q2 2024 buy was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.29B increase.
- Squarepoint's biggest Q2 2024 reduction was Apple, cutting an estimated $210M.
- Squarepoint fully exited DraftKings in Q2 2024, selling an estimated $94.6M.
- Squarepoint's ten largest holdings make up 18% of its $60.5B portfolio in Q2 2024.
- Squarepoint opened 882 new positions and closed 849 in Q2 2024.
- Squarepoint's portfolio value rose 4.1% quarter-over-quarter to $60.5B.
Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.